Binergia
PHARMACEUTICAL COMPANY
JSC Binergia is a modern developing national pharmaceutical company. The company is active in the development, registration, production and marketing of medicinal products intended for the provision of medical care, both inpatient and outpatient.
In particular, Binergia JSC is actively developing with regard to the registration and production of anesthetics.
Good health is critical to all of us, which is why Binergia JSC never stops moving forward. Our team continues to search for solutions to include modern, high quality and effective, and most importantly affordable drugs in the product portfolio.
Company development strategy
Within the framework of the strategy for the development of the pharmaceutical industry of the Russian Federation, which is aimed at reducing the dependence of domestic health care on the import of medicines, Binergia JSC has identified the following areas of its activities as priorities:
- Production of high-tech generics and innovative bioorganic drugs.
- Development and production of active pharmaceutical ingredients.
- Research, development and production of innovative pharma drugs.
- Market launch of modern and affordable medicines.
- Ensuring control and maintaining a high level of quality at all stages, from an idea to production.
In addition, the company is focused on the production of drugs that are significant to society. More than 60% of the range of products are drugs that are included in the List of Vital and Essential Medicines (VEM). These are critical drugs for both patients and the health care system as a whole.
Being in dynamic development, we strive to provide the population of Russia with safe, high-quality, effective and, least but not last, affordable medicines.
Drug Safety
In accordance with the legislation of the Russian Federation, the specialists of Binergia JSC monitor carefully the quality of the products and the effectiveness and safety of manufactured drugs.
The company implements a set of pharmacovigilance measures to improve the quality of medicines, identify, evaluate and prevent adverse side effects and increase the safety of drug therapy.
Pharmacovigilance is a set of activities that are related to scientific research and activities aimed at identifying, assessing and understanding the possible negative consequences of the medical use of drugs, preventing their occurrence and protecting patients.
For us, each stage in the development of drugs is a huge layer of work, the goal of which is a healthy life for people.
If an undesirable reaction occurs when using Binergia pharma products, immediately contact our specialist:
- +7(495) 775-41-43 add. 700
- +7 985 221 43 88
- safety@binergia.ru
Quality Control
Binergia's medicinal products are manufactured in accordance with GMP international standards (Good Manufacturing Practice) and ISO:9001.
The company supervises the quality of its products at all stages of pharmaceutical circulation: starting from the receipt of raw materials, development, research in the post-registration period and not stopping after the drugs enter the market.
The company has its own analytical control laboratory, which is equipped with modern equipment from leading world manufacturers and cooperates with leading laboratories and R&D centers nationwide.
This allows us to guarantee the high quality of our pharma drugs.